Global Orally Disintegrating Films (ODFs) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orally Disintegrating Films (ODFs) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Orally disintegrating films can be produced with different polymers, which is the main responsible for properties such as disintegration time and mucoadhesiveness, aiming at controlled and more effective release of the active compounds.
Orally Disintegrating Films (ODFs) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orally Disintegrating Films (ODFs) market is projected to reach US$ 959.6 million in 2029, increasing from US$ 624 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Clinic and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Orally Disintegrating Films (ODFs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Orally Disintegrating Films (ODFs) key manufacturers include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI) are top 3 players and held % sales share in total in 2022.
Orally Disintegrating Films (ODFs) can be divided into Orodispersible Film and Oromucosal Film, etc. Orodispersible Film is the mainstream product in the market, accounting for % sales share globally in 2022.
Orally Disintegrating Films (ODFs) is widely used in various fields, such as Hospital and Clinic, Drug Store and E-commerce,, etc. Hospital and Clinic provides greatest supports to the Orally Disintegrating Films (ODFs) industry development. In 2022, global % sales of Orally Disintegrating Films (ODFs) went into Hospital and Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orally Disintegrating Films (ODFs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Aquestive Therapeutics
Kyukyu Pharmaceutical
BioDelivery(BDSI)
IntelGenx
Tapemark
Shilpa Therapeutics
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Orodispersible Film
Oromucosal Film
Hospital and Clinic
Drug Store
E-commerce
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orally Disintegrating Films (ODFs) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orally Disintegrating Films (ODFs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orally Disintegrating Films (ODFs) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orally Disintegrating Films (ODFs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orally Disintegrating Films (ODFs) introduction, etc. Orally Disintegrating Films (ODFs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orally Disintegrating Films (ODFs) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Orally Disintegrating Films (ODFs) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orally Disintegrating Films (ODFs) market is projected to reach US$ 959.6 million in 2029, increasing from US$ 624 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Clinic and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Orally Disintegrating Films (ODFs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Orally Disintegrating Films (ODFs) key manufacturers include Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI) are top 3 players and held % sales share in total in 2022.
Orally Disintegrating Films (ODFs) can be divided into Orodispersible Film and Oromucosal Film, etc. Orodispersible Film is the mainstream product in the market, accounting for % sales share globally in 2022.
Orally Disintegrating Films (ODFs) is widely used in various fields, such as Hospital and Clinic, Drug Store and E-commerce,, etc. Hospital and Clinic provides greatest supports to the Orally Disintegrating Films (ODFs) industry development. In 2022, global % sales of Orally Disintegrating Films (ODFs) went into Hospital and Clinic filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orally Disintegrating Films (ODFs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Aquestive Therapeutics
Kyukyu Pharmaceutical
BioDelivery(BDSI)
IntelGenx
Tapemark
Shilpa Therapeutics
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical
Segment by Type
Orodispersible Film
Oromucosal Film
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orally Disintegrating Films (ODFs) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orally Disintegrating Films (ODFs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orally Disintegrating Films (ODFs) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orally Disintegrating Films (ODFs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orally Disintegrating Films (ODFs) introduction, etc. Orally Disintegrating Films (ODFs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orally Disintegrating Films (ODFs) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.